{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:48:09Z","timestamp":1761540489877,"version":"3.44.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.seminhematol.2003.10.008","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T12:22:23Z","timestamp":1074169343000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience"],"prefix":"10.1053","volume":"41","author":[{"given":"Johanna A","family":"Kremer Hovinga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Dirk","family":"Studt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"L\u00e4mmle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2003.10.008_BIB1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the United States\u2014Analysis of national mortality data, 1968\u20131991","volume":"50","author":"Torok","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2000.01941.x","article-title":"Management of thrombotic thrombocytopenic purpura","volume":"109","author":"Rock","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB3","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc NY Pathol Soc"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.V2.6.542.542","article-title":"Thrombotic thrombocytopenic purpura","volume":"2","author":"Singer","year":"1947","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","article-title":"Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit","volume":"88","author":"Dent","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB8","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB9","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB10","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB11","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor-cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB16","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood","volume":"130","author":"Soejima","year":"2001","journal-title":"J Biochem (Tokyo)"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB19","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood-2002-05-1397","article-title":"Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)","volume":"100","author":"Plaimauer","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197806152982407","article-title":"Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia","volume":"298","author":"Upshaw","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V16.1.943.943","article-title":"Studies on thrombopoiesis. I: A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency","volume":"16","author":"Schulman","year":"1960","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB22","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2002-08-2399","article-title":"Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP","volume":"101","author":"Schneppenheim","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.2003.04183.x","article-title":"ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13","volume":"120","author":"Antoine","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB25","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1182\/blood-2002-12-3796","article-title":"ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity","volume":"101","author":"Savasan","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1523-1755.63.6s.1.x","article-title":"Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency","volume":"63","author":"Assink","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB29","first-page":"1761","article-title":"Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study","volume":"20","author":"H\u00e9non","year":"1991","journal-title":"Presse Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"96","author":"George","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","article-title":"Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias","volume":"120","author":"Allford","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB33","first-page":"905","article-title":"H\u00e4molytisch-ur\u00e4mische Syndrome","volume":"85","author":"Gasser","year":"1955","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(99)01251-9","article-title":"Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak","volume":"354","author":"Dundas","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02982558","article-title":"Upshaw-Schulman syndrome revisited","volume":"74","author":"Kinoshita","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4414\/smw.2003.10242","article-title":"Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies","volume":"133","author":"Studt","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB40","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1538-7836.2003.00385.x","article-title":"Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma","volume":"1","author":"Studt","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","article-title":"Carcinoma-associated hemolytic-uremic syndrome","volume":"3","author":"Cantrell","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2007-994923","article-title":"Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in the cancer patient","volume":"25","author":"Gordon","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB44","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/00006450-200105000-00008","article-title":"von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome","volume":"49","author":"Tsai","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1537-2995.2002.00100.x","article-title":"Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity","volume":"42","author":"Mori","year":"2002","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4065\/78.4.421","article-title":"Posttransplantation thrombotic thrombocytopenic purpura","volume":"78","author":"Elliott","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615949","article-title":"von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome","volume":"85","author":"Hunt","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB49","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","article-title":"Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome","volume":"142","author":"Veyradier","year":"2003","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2001-12-0166","article-title":"von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"100","author":"Remuzzi","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1538-7836.2003.00170.x","article-title":"Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No","volume":"1","author":"Remuzzi","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1538-7836.2003.00169.x","article-title":"Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes","volume":"1","author":"Tsai","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB54","first-page":"1087","article-title":"Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura","volume":"112","author":"Loof","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB55","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood.V98.6.1842","article-title":"Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders","volume":"98","author":"Moore","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/beha.2001.0142","article-title":"Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome","volume":"14","author":"Furlan","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2141.1994.tb05122.x","article-title":"Anti-CD36 antibodies in thrombotic thrombocytopenic purpura","volume":"88","author":"Tandon","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2141.1998.01070.x","article-title":"Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders","volume":"103","author":"Schultz","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB59","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-122-8-199504150-00002","article-title":"Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group","volume":"122","author":"Shumak","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB61","first-page":"1192","article-title":"Thrombotic thrombocytopenic purpura in 13 Dutch centres","volume":"141","author":"Kappers-Klunne","year":"1997","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-138-2-200301210-00011","article-title":"Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab","volume":"138","author":"Zheng","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB63","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-05-1616","article-title":"Non-neutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura (TTP)","author":"Scheiflinger","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.10.008_BIB64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/asheducation-2002.1.315","article-title":"Platelets","author":"George","year":"2002","journal-title":"Hematology (Am Soc Hematol Educ Program)"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:12:02Z","timestamp":1758521522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196303002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0037196303002816"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.10.008","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}